You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
巴菲特二季度清倉Biogen 默克持倉砍半 減持通用汽車 增持Kroger

今年第二季度,巴菲特領導的伯克希爾哈撒韋股票投資倉位相比一季度變動不大,清倉Biogen等三隻個股,新進一隻個股,減持兩家醫藥巨頭、通用汽車、雪佛龍等八隻,僅增持Kroger等三隻。

二季度伯克希爾披露的持倉市值增長8.4%,增至2930億美元,跑贏大盤,同期標普500漲5.8%。

伯克希爾二季度清倉的股票合計市值將近6.8億美元,其中包括:

塗料公司Axalta(AXTA)清倉1390萬股,市值4.108億美元;

研發阿爾茨海默症藥物等神經系統疾病藥物的生物科技公司Biogen(BIIB)清倉共64.3022萬股,市值1.799億美元;

電信公司Liberty Global(LBTYA)A類股清倉336萬股,市值8620萬美元。

伯克希爾減持的八隻個股主要包括:,

醫藥巨頭默克(MRK)減持958萬股,持有股份數較一季度減少約49%,降至915.7萬股,市值7.12億美元,佔流通股總數的0.36%;

通用汽車(GM)減持700萬股,環比持股減少10%,降至6000萬股,市值35.5億美元,佔流通股總數的4.1%;

醫藥巨頭百時美施貴寶(BMY)減持474萬股,持股環比減少15%,降至2630萬股,市值17.6億美元, 佔流通股總數的1.2%;

生物製藥公司艾伯維(ABBV)減持234萬股,持股環比減少10%,降至2050萬股,市值23.1億美元,佔流通股總數的1.2%;

電信公司Liberty Global(LBTYA)C類股減持546萬股,持股環比減少74%,降至188萬股,市值5070萬美元;

雪佛龍(CVX)減持54.8352萬股,持股環比減少2.3%,降至2310萬股,市值24.2億美元, 佔流通股總數的1.2%。

此外還減持了保險與風險管理公司Marsh & McLennan Cos.(MMC)和美國銀行US Bancorp(USB)。

伯克希爾二季度僅新進一隻個股——醫療保健公司Organon(OGN),當季持有155萬股,市值4691萬美元。

伯克希爾二季度增持個股分別有:

連鎖超市Kroger(KR)增持1070萬股,較一季度持股數增加21%,增至6180萬股,市值23.7億美元,佔流通股總數的8.3%;

家居用品零售商RH(RH)增持3.5519萬股,環比持股增長2%,增至179萬股,市值12.2億美元,佔流通股總數的8.5%;

保險集團怡安(AON)增持29.9854萬股,環比持股增長7.3%,增至440萬股,市值10.5億美元,佔流通股總數的1.9%。

b50fd931-bfe8-4a10-af16-dd636e1e9a65.jpg

截至二季度末,伯克希爾的前五大重倉股均未有增減變動,分別是:

  • 蘋果8.871億股,市值1215億美元,佔披露持倉總規模的41%;

  • 美國銀行10.1億股,市值416億美元;

  • 美國運通1.516億股,市值251億美元;

  • 可口可樂4億股,市值216億美元;

  • 卡夫亨氏3.256億股,市值133億美元。

伯克希爾的十大重倉股中,二季度僅US Bancorp(USB)持倉有變動,當季減持將近80萬股,持股降至近1.29億股,市值73.42億美元,排名仍在第八位。

分板塊看,二季度持倉佔比最多的仍是信息技術,佔比將近42%,第二位是佔近32%的金融,必需消費品佔近13%,公用事業和通信佔逾3%,醫療健康也佔3%以上,非必需消費品佔逾2%。

8fd8e2b9-1b08-4e4f-8767-dc5a90937028.jpg

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account